Critical care medicine
-
Critical care medicine · Nov 1995
Randomized Controlled Trial Comparative Study Clinical TrialParenteral magnesium sulfate versus amiodarone in the therapy of atrial tachyarrhythmias: a prospective, randomized study.
To compare the efficacy of parenteral magnesium sulfate vs. amiodarone in the therapy of atrial tachyarrhythmias in critically ill patients. ⋯ Intravenous magnesium sulfate is superior to amiodarone in the conversion of acute atrial tachyarrhythmias, while initial slowing of ventricular response rate in nonconverters appears equally efficacious with both agents.
-
Critical care medicine · Nov 1995
Clinical TrialMilrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery.
To evaluate the hemodynamic effects of intravenous milrinone in neonates with low cardiac output after cardiac surgery. ⋯ Administration of milrinone in neonates with low cardiac output after cardiac surgery lowers filling pressures, systemic and pulmonary arterial pressures, and systemic and pulmonary vascular resistances, while improving cardiac index. Milrinone increases heart rate without altering myocardial oxygen consumption. While milrinone appears to be effective and safe during short-term use, the relative distribution of inotropic and vasodilatory properties of milrinone remains to be elucidated.
-
Critical care medicine · Nov 1995
Clinical Trial Controlled Clinical TrialDifficulties in predicting outcome in cardiac surgery patients.
To evaluate a novel combination of preoperative, intraoperative, and postoperative variables (including the Parsonnet, and the Acute Physiology and Chronic Health Evaluation II and III [APACHE II and III] scores) in cardiac surgery patients in order to predict hospital outcome, complications, and length of stay. ⋯ Cardiac surgery remains a difficult area for outcome prediction. A combination of intraoperative and postoperative variables can improve predictive ability.
-
Critical care medicine · Nov 1995
Comparative StudyPrediction of mortality in neonates with congenital diaphragmatic hernia treated with extracorporeal membrane oxygenation.
To determine if data collected by the Extracorporeal Life Support Organization Registry could be used to identify neonates with congenital diaphragmatic hernia who had a > 90% mortality rate, despite the use of extracorporeal membrane oxygenation (ECMO) support. ⋯ Although a number of factors identify neonates with diaphragmatic hernia as being at higher risk of dying despite ECMO support, data currently collected by the neonatal Extracorporeal Life Support Organization Registry do not allow clinicians to effectively discriminate nonsurvivors from survivors.